Thomas Malley - 29 Jun 2021 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role
Director
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact for Thomas R. Malley
Issuer symbol
KNSA
Transactions as of
29 Jun 2021
Net transactions value
$0
Form type
4
Filing time
30 Jun 2021, 16:21:35 UTC
Previous filing
23 Jun 2021
Next filing
23 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Share Option Award $0 +33,237 $0.000000 33,237 29 Jun 2021 Class A Common Shares 33,237 $14.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2021.